Natural Alternatives International, Inc.

NasdaqGM NAII

Natural Alternatives International, Inc. Shareholders' Equity for the quarter ending September 30, 2024: USD 80.19 M

Natural Alternatives International, Inc. Shareholders' Equity is USD 80.19 M for the quarter ending September 30, 2024, a -9.72% change year over year. Shareholders' equity are the residual interest in the assets of a company after deducting liabilities, representing the shareholders' ownership claim.
  • Natural Alternatives International, Inc. Shareholders' Equity for the quarter ending September 30, 2023 was USD 88.81 M, a -1.16% change year over year.
  • Natural Alternatives International, Inc. Shareholders' Equity for the quarter ending September 30, 2022 was USD 89.86 M, a 6.33% change year over year.
  • Natural Alternatives International, Inc. Shareholders' Equity for the quarter ending September 30, 2021 was USD 84.50 M, a 18.80% change year over year.
  • Natural Alternatives International, Inc. Shareholders' Equity for the quarter ending September 30, 2020 was USD 71.13 M, a -8.11% change year over year.
Key data
Date Shareholders' Equity Minority Interest Total Equity Total Stockholders Equity and Liabilities
Market news
Loading...
SV Wall Street
NasdaqGM: NAII

Natural Alternatives International, Inc.

CEO Mr. Mark A. LeDoux J.D.
IPO Date Oct. 28, 1993
Location United States
Headquarters 1535 Faraday Avenue
Employees 296
Sector Healthcare
Industries
Description

Natural Alternatives International, Inc. engages in formulating, manufacturing, and marketing nutritional supplements in the United States, Europe, Asia, and internationally. The company operates in two segments, Private-Label Contract Manufacturing, and Patent and Trademark Licensing. It offers private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbal, and other nutritional supplements, as well as other health care products. The company also provides strategic partnering services, such as customized product formulation, clinical studies, manufacturing, marketing support, international regulatory and label law compliance, international product registration, packaging in multiple formats and labeling design, scientific research, proprietary ingredients, customer-specific nutritional product formulation, product testing and evaluation, packaging and delivery system design, and regulatory review. In addition, it sells beta-alanine ingredient under the CarnoSyn and SR CarnoSyn names. The company manufactures products in various forms, including capsules, tablets, chewable wafers, and powders. Its private-label contract manufacturing customers include companies that market nutritional supplements through direct sales marketing channels, direct to consumer e-commerce channels, and retail stores. Natural Alternatives International, Inc. was founded in 1980 and is headquartered in Carlsbad, California.

Similar companies

LWAY

Lifeway Foods, Inc.

USD 23.04

-2.21%

LFVN

LifeVantage Corporation

USD 21.16

-5.54%

CENT

Central Garden & Pet Company

USD 36.49

-0.90%

SENEA

Seneca Foods Corporation

USD 72.91

1.05%

NATR

Nature's Sunshine Products, Inc.

USD 13.91

-5.50%

StockViz Staff

February 4, 2025

Any question? Send us an email